C237-0265 Screening compound: N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide

C237-0265 Screening compound: N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide
C237-0265 Screening compound: N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C237-0265
N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C237-0265

Molecular Formula

C29H36N4O3 (C29 H36 N4 O3)

Compound Name

N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide

IUPAC name

N-[2-(35-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-N'-(2-ethoxyphenyl)butanediamide

SMILES

CCOc(cccc1)c1NC(CCC(Nc1cc2c(C)cc(N3CC(C)CC(C)C3)nc2cc1)=O)=O

InChI

InChI=1S/C29H36N4O3/c1-5-36-26-9-7-6-8-25(26)32-29(35)13-12-28(34)30-22-10-11-24-23(16-22)21(4)15-27(31-24)33-17-19(2)14-20(3)18-33/h6-11,15-16,19-20H,5,12-14,17-18H2,1-4H3,(H,30,34)(H,32,35)

InChI Key

YJKAFXUIKPMQKM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14733799

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.63

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.662

Distribution Coefficient, logD

5.661

Water Solubility, LogSw

-5.51

Polar Surface Area

63.892

Acid Dissociation Constant (pKa)

11.03

Base Dissociation Constant (pKb)

9.48

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

41.40

C237-0265 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GABA Library (7115 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with C237-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C237-0265?
Check Price and Availability of C237-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C237-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C237-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C237-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C237-0265 available by request